BMC Cancer

official impact factor 3.15

Open Access Highly Access

Gene expression patterns associated with p53 status in breast cancer

Melissa A Troester*, Jason I Herschkowitz, Daniel S Oh, Xiaping He, Katherine A Hoadley, Claire S Barbier and Charles M Perou

BMC Cancer 2006, 6:276 doi:10.1186/1471-2407-6-276

Accesses  

  • Last 30 days: 78 accesses
  • Last 365 days: 1055 accesses
  • All time: 9629 accesses

Cited by

BioMed Central: 6 citations

Research article   Open Access

Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial

Lynnette Fernández-Cuesta, Catherine Oakman, Priscila Falagan-Lotsch, Ke-seay Smoth, Emmanuel Quinaux, Marc Buyse, M Dolci, Evandro Azambuja, Pierre Hainaut, Patrizia Dell'Orto, Denis Larsimont, Prudence A Francis, John Crown, Martine Piccart-Gebhart, Giuseppe Viale, Angelo Leo, Magali Olivier Breast Cancer Research 2012, 14:R70 (2 May 2012)

Research article   Open Access

Expression signatures of TP53 mutations in serous ovarian cancers

Marcus Q Bernardini, Tsukasa Baba, Paula S Lee, Jason C Barnett, Gregory P Sfakianos, Angeles Secord, Susan K Murphy, Edwin Iversen, Jeffrey R Marks, Andrew Berchuck BMC Cancer 2010, 10:237 (26 May 2010)

Research article   Open Access Highly Accessed

An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer

Andrea H Bild, Joel S Parker, Adam M Gustafson, Chaitanya R Acharya, Katherine A Hoadley, Carey Anders, P Kelly Marcom, Lisa A Carey, Anil Potti, Joseph R Nevins, Charles M Perou Breast Cancer Research 2009, 11:R55 (28 July 2009)

Research article   Open Access Highly Accessed

A compact VEGF signature associated with distant metastases and poor outcomes

Zhiyuan Hu, Cheng Fan, Chad Livasy, Xiaping He, Daniel S Oh, Matthew G Ewend, Lisa A Carey, Subbaya Subramanian, Robert West, Francis Ikpatt, Olufunmilayo I Olopade, Matt van de Rijn, Charles M Perou BMC Medicine 2009, 7:9 (16 March 2009)

Expression of the 13-gene VEGF (vascular endothelial growth factor) profile occurs in distant cancer metastases and is predictive of poor outcome, but may help to target anti-angiogenesis therapies.

Viewpoint   Free

Regulation of cancer stem cells by p53

D Joseph Jerry, Luwei Tao, Haoheng Yan Breast Cancer Research 2008, 10:304 (29 August 2008)

Review   Free Highly Accessed

Molecular targeted therapies for breast cancer treatment

Claus M Schlotter, Ulf Vogt, Heike Allgayer, Burkhard Brandt Breast Cancer Research 2008, 10:211 (24 July 2008)